Simorgh Sara, Milan Peiman Brouki, Saadatmand Maryam, Bagher Zohreh, Gholipourmalekabadi Mazaher, Alizadeh Rafieh, Hivechi Ahmad, Arabpour Zohreh, Hamidi Masoud, Delattre Cédric
Cellular and Molecular Research Centre, Iran University of Medical Sciences, Tehran 1591639675, Iran.
Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 1591639675, Iran.
Materials (Basel). 2021 Jul 13;14(14):3909. doi: 10.3390/ma14143909.
For bone tissue engineering, stem cell-based therapy has become a promising option. Recently, cell transplantation supported by polymeric carriers has been increasingly evaluated. Herein, we encapsulated human olfactory ectomesenchymal stem cells (OE-MSC) in the collagen hydrogel system, and their osteogenic potential was assessed in vitro and in vivo conditions. Collagen type I was composed of four different concentrations of (4 mg/mL, 5 mg/mL, 6 mg/mL, 7 mg/mL). SDS-Page, FTIR, rheologic test, resazurin assay, live/dead assay, and SEM were used to characterize collagen hydrogels. OE-MSCs encapsulated in the optimum concentration of collagen hydrogel and transplanted in rat calvarial defects. The tissue samples were harvested after 4- and 8-weeks post-transplantation and assessed by optical imaging, micro CT, and H&E staining methods. The highest porosity and biocompatibility were confirmed in all scaffolds. The collagen hydrogel with 7 mg/mL concentration was presented as optimal mechanical properties close to the naïve bone. Furthermore, the same concentration illustrated high osteogenic differentiation confirmed by real-time PCR and alizarin red S methods. Bone healing has significantly occurred in defects treated with OE-MSCs encapsulated hydrogels in vivo. As a result, OE-MSCs with suitable carriers could be used as an appropriate cell source to address clinical bone complications.
对于骨组织工程而言,基于干细胞的疗法已成为一种有前景的选择。近来,由聚合物载体支持的细胞移植受到了越来越多的评估。在此,我们将人嗅球外胚层间充质干细胞(OE-MSC)封装于胶原水凝胶系统中,并在体外和体内条件下评估其成骨潜能。I型胶原由四种不同浓度(4mg/mL、5mg/mL、6mg/mL、7mg/mL)组成。采用SDS-聚丙烯酰胺凝胶电泳、傅里叶变换红外光谱、流变学测试、刃天青检测、活/死检测及扫描电子显微镜对胶原水凝胶进行表征。将封装于最佳浓度胶原水凝胶中的OE-MSCs移植到大鼠颅骨缺损处。在移植后4周和8周采集组织样本,并通过光学成像、显微CT及苏木精-伊红染色方法进行评估。所有支架均证实具有最高的孔隙率和生物相容性。浓度为7mg/mL的胶原水凝胶呈现出接近天然骨的最佳力学性能。此外,通过实时聚合酶链反应和茜素红S方法证实相同浓度具有高成骨分化能力。在体内,用封装有OE-MSCs的水凝胶治疗的缺损处已显著发生骨愈合。因此,具有合适载体的OE-MSCs可作为解决临床骨并发症的合适细胞来源。